CGAS and neoplasm: The activation of cGAS-STING pathway by tumor-derived dsDNA [241] has tremendous potential to improve antitumor immunity, playing an essential role in DC recognition of dying tumor cells, by generating I-IFN response and potently enhanced antitumor CTL responses [241, 242, 279, 282].